Gilead, Indian Generic Cos. Reach Deals Over Hep C Drug
Gilead Sciences has reached deals with seven generic drug manufacturers in India to sell cheaper versions of its $1,000-per-pill hepatitis C drug Sovaldi, roughly a month after the company won the...To view the full article, register now.
Already a subscriber? Click here to view full article